Silver Book Fact

A 2002 study found that image-guided percutaneous needle biopsies are between 3 and 7 times more cost-effective than open surgical biopsies, require a shorter procedure time, result in fewer infections, and allow earlier treatment if cancer is found.

Jelinek, James S., Mark D. Murphey, James A. Welker, Robert M. Henshaw, Mark J. Kransdorf, Barry M. Shmookler, and Martin M. Malawer. Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors. Radiology. 2002; 223: 731-7. http://radiology.rsnajnls.org/cgi/content/abstract/223/3/731

Reference

Title
Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors
Publication
Radiology
Publication Date
2002
Authors
Jelinek, James S., Mark D. Murphey, James A. Welker, Robert M. Henshaw, Mark J. Kransdorf, Barry M. Shmookler, and Martin M. Malawer
Pages
731-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • Between 2008 and 2010, use of colonoscopy for the treatment and prevention of colon cancer saved an average of $150,364 each year, per person affected.  
  • Investments in research since the 1970s have generated $1.9 trillion of value to society overall.  
  • Over the next 10 years, the number of cancer survivors in the U.S. is predicted to grow from 14.5 million to nearly 19 million (9.3 million men and 9.6 million…  
  • Following the current path, the colon cancer incidence rate will increase by 31.8% between 2003 and 2023 (447,000 people). If an alternative path is taken, there will be 17.7% (79,000…